Earnings Call · Q2 FY2026·2026-07-30

Q2 26EPS +12.50%·Rev n/aQ1 26EPS +38.96%·Rev n/aQ4 25EPS +16.67%·Rev n/aQ3 25EPS +21.43%·Rev n/a⚠ consensus missing

Amneal Pharmaceuticals, Inc. AMRX

Tony DiMeo — Head of Investor Relations

Chirag Patel — Co-Founder and Co-CEO

Chintu Patel — Co-Founder and Co-CEO

Anastasios Konidaris — Chief Financial Officer

−3.1%1d on move date3d−1.3%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more AMRX calls or request research access.

More AMRX calls Browse calls Request research access